OBJECTIVE: Psychotherapy for borderline personality disorder (BPD) has been associated with problematically low treatment completion rates. METHOD: PsycInfo and Medline were systematically searched to identify studies providing information on treatment completion in psychotherapy models that have been shown to be effective for BPD. A meta-analysis of treatment completion rates and a narrative analysis of factors predicting dropout were conducted. RESULTS: Forty-one studies were included, with completion rates ranging from 36% to 100%- a substantial between-study heterogeneity. Random effects meta-analyses yielded an overall completion rate of 75% (95% CI: 68-82%) for interventions of <12 months duration, and 71% (95% CI: 65-76%) for longer interventions. Egger's test for publication bias was significant for both analyses (P ≤ 0.01). Study characteristics such as treatment model and treatment setting did not explain between-study heterogeneity. In individual studies, factors predicting dropout status included commitment to change, the therapeutic relationship and impulsivity, whilst sociodemographics were consistently non-predictive. CONCLUSION: Borderline personality disorder should no longer be associated with high rates of dropout from treatment. However, the substantial variation in completion rates between studies remains unexplained. Research on the psychological processes involved in dropping out of treatment could further improve dropout rates.
OBJECTIVE: Psychotherapy for borderline personality disorder (BPD) has been associated with problematically low treatment completion rates. METHOD: PsycInfo and Medline were systematically searched to identify studies providing information on treatment completion in psychotherapy models that have been shown to be effective for BPD. A meta-analysis of treatment completion rates and a narrative analysis of factors predicting dropout were conducted. RESULTS: Forty-one studies were included, with completion rates ranging from 36% to 100%- a substantial between-study heterogeneity. Random effects meta-analyses yielded an overall completion rate of 75% (95% CI: 68-82%) for interventions of <12 months duration, and 71% (95% CI: 65-76%) for longer interventions. Egger's test for publication bias was significant for both analyses (P ≤ 0.01). Study characteristics such as treatment model and treatment setting did not explain between-study heterogeneity. In individual studies, factors predicting dropout status included commitment to change, the therapeutic relationship and impulsivity, whilst sociodemographics were consistently non-predictive. CONCLUSION:Borderline personality disorder should no longer be associated with high rates of dropout from treatment. However, the substantial variation in completion rates between studies remains unexplained. Research on the psychological processes involved in dropping out of treatment could further improve dropout rates.
Authors: Peter Fonagy; Mario Speranza; Patrick Luyten; Michael Kaess; Christel Hessels; Martin Bohus Journal: Eur Child Adolesc Psychiatry Date: 2015-08-14 Impact factor: 4.785
Authors: M Alexandra Kredlow; Kristin L Szuhany; Stephen Lo; Haiyi Xie; Jennifer D Gottlieb; Stanley D Rosenberg; Kim T Mueser Journal: Psychiatry Res Date: 2017-01-04 Impact factor: 3.222
Authors: Daniel Fernández; Daniel Vigo; Nancy A Sampson; Irving Hwang; Sergio Aguilar-Gaxiola; Ali O Al-Hamzawi; Jordi Alonso; Laura Helena Andrade; Evelyn J Bromet; Giovanni de Girolamo; Peter de Jonge; Silvia Florescu; Oye Gureje; Hristo Hinkov; Chiyi Hu; Elie G Karam; Georges Karam; Norito Kawakami; Andrzej Kiejna; Viviane Kovess-Masfety; Maria E Medina-Mora; Fernando Navarro-Mateu; Akin Ojagbemi; Siobhan O'Neill; Marina Piazza; Jose Posada-Villa; Charlene Rapsey; David R Williams; Miguel Xavier; Yuval Ziv; Ronald C Kessler; Josep M Haro Journal: Psychol Med Date: 2020-04-28 Impact factor: 7.723
Authors: Crispin Day; Jackie Briskman; Mike J Crawford; Lisa Foote; Lucy Harris; Janet Boadu; Paul McCrone; Mary McMurran; Daniel Michelson; Paul Moran; Liberty Mosse; Stephen Scott; Daniel Stahl; Paul Ramchandani; Timothy Weaver Journal: Health Technol Assess Date: 2020-03 Impact factor: 4.014
Authors: Rosemarie McCabe; Jens Bullenkamp; Lars Hansson; Christoph Lauber; Rafael Martinez-Leal; Wulf Rössler; Hans Joachim Salize; Bengt Svensson; Francisco Torres-Gonzalez; Rob van den Brink; Durk Wiersma; Stefan Priebe Journal: PLoS One Date: 2012-04-27 Impact factor: 3.240
Authors: Christina Katsakou; Stamatina Marougka; Kirsten Barnicot; Mark Savill; Hayley White; Kate Lockwood; Stefan Priebe Journal: PLoS One Date: 2012-05-17 Impact factor: 3.240
Authors: Cristina Giner-Bartolomé; Ana B Fagundo; Isabel Sánchez; Susana Jiménez-Murcia; Juan J Santamaría; Robert Ladouceur; José M Menchón; Fernando Fernández-Aranda Journal: Front Psychol Date: 2015-07-14